These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24042414)

  • 1. [Correlation between cognitive impairment and plasma levels of clusterin/ApoJ in Parkinson disease patients not affected by dementia].
    Niccoli Asabella A; Ruggeri M; Rubini D; Polimeno L; Spinelli C; Polito M; Pennelli M; Altini C; De Caro MS; Defazio G; Rubini G
    Recenti Prog Med; 2013; 104(7-8):393-7. PubMed ID: 24042414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increases of pentraxin 3 plasma levels in patients with Parkinson's disease.
    Lee HW; Choi J; Suk K
    Mov Disord; 2011 Nov; 26(13):2364-70. PubMed ID: 21953577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease.
    van Dijk KD; Jongbloed W; Heijst JA; Teunissen CE; Groenewegen HJ; Berendse HW; van de Berg WD; Veerhuis R
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1079-83. PubMed ID: 23932065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R
    J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease.
    Chung CC; Chan L; Chen JH; Bamodu OA; Chiu HW; Hong CT
    FASEB J; 2021 Oct; 35(10):e21895. PubMed ID: 34478572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.
    Delgado-Alvarado M; Gago B; Navalpotro-Gomez I; Jiménez-Urbieta H; Rodriguez-Oroz MC
    Mov Disord; 2016 Jun; 31(6):861-81. PubMed ID: 27193487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.
    Fiorenzato E; Biundo R; Cecchin D; Frigo AC; Kim J; Weis L; Strafella AP; Antonini A
    J Alzheimers Dis; 2018; 66(1):229-237. PubMed ID: 30282359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
    Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
    Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma insulin-like growth factor 1 is associated with cognitive impairment in Parkinson's disease.
    Ma J; Jiang Q; Xu J; Sun Q; Qiao Y; Chen W; Wu Y; Wang Y; Xiao Q; Liu J; Tang H; Chen S
    Dement Geriatr Cogn Disord; 2015; 39(5-6):251-6. PubMed ID: 25661865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
    Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
    Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mild cognitive impairment in Parkinson's disease].
    Wada K; Nakashima K
    Brain Nerve; 2012 Dec; 64(12):1365-75. PubMed ID: 23209063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study.
    Pellecchia MT; Savastano R; Moccia M; Picillo M; Siano P; Erro R; Vallelunga A; Amboni M; Vitale C; Santangelo G; Barone P
    J Neural Transm (Vienna); 2016 Dec; 123(12):1399-1402. PubMed ID: 27682634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau protein, beta-amyloid₁₋₄₂ and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia.
    Vranová HP; Hényková E; Kaiserová M; Menšíková K; Vaštík M; Mareš J; Hluštík P; Zapletalová J; Strnad M; Stejskal D; Kaňovský P
    J Neurol Sci; 2014 Aug; 343(1-2):120-4. PubMed ID: 24928081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A correlativity study of plasma APL1β28 and clusterin levels with MMSE/MoCA/CASI in aMCI patients.
    Meng Y; Li H; Hua R; Wang H; Lu J; Yu X; Zhang C
    Sci Rep; 2015 Oct; 5():15546. PubMed ID: 26503441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma levels of phospholipid in Parkinson's disease with mild cognitive impairment.
    Li Z; Zhang J; Sun H
    J Clin Neurosci; 2015 Aug; 22(8):1268-71. PubMed ID: 26055959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography.
    Hansen AK; Damholdt MF; Fedorova TD; Knudsen K; Parbo P; Ismail R; Østergaard K; Brooks DJ; Borghammer P
    Mov Disord; 2017 Jun; 32(6):922-927. PubMed ID: 28256006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.